Sonoma Pharmaceuticals grants 180,000 stock options to executive officers at $0.18 per share

Sonoma Pharmaceuticals, Inc.

CEO Amy Trombly, interim CFO Jerry Dvonch, and COO Bruce Thornton each received 60,000 options.
Exercise price of $0.18 is based on December 29, 2023 closing price.
Options vest in three equal annual tranches; non-employee directors waived their grants.
All options fully vest upon a change of control.
Total options granted to executive officers: 180,000.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.